insights_auto
Why is DFTX down 6.62%?
Dive Deeperchevron_right
DFTX:NASDAQ
Definium Therapeutics Inc
$37.65
arrow_downward
-6.62%(-2.67) 1D
$38.19
arrow_upward
+1.43% (+0.54)bedtimeAfter hours
Closed: Sep 23, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$40.03
High
$40.04
Low
$37.16
Mkt. cap
5.06B
Avg. vol.
2.31M
Volume
2.71M
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
Open
$40.03
High
$40.04
Low
$37.16
Mkt. cap
5.06B
Avg. vol.
2.31M
Volume
2.71M
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com